Lung-CAD

Lung-CAD is a software device employing deep learning algorithms to analyze adult chest radiographs for signs of lung hyperinflation, presenting findings as DICOM overlays with bounding boxes around regions of interest to assist physicians in concurrent reads. Its scientific basis is validated through performance testing showing high standalone sensitivity and specificity, and clinical studies demonstrating improved reader accuracy when using the device.

Lung-CAD is a computer-assisted detection (CADe) software device designed to aid physicians in interpreting adult chest radiographs by identifying potential lung hyperinflation. Utilizing deep learning and computer vision techniques, the software analyzes images and, if regions of interest (ROIs) indicative of lung hyperinflation are detected, generates a DICOM Presentation State file. This output overlay includes bounding boxes around the identified ROIs, labeled as "Lung hyperinflation," and can be toggled on or off within a Picture Archiving and Communication System (PACS) viewer. The device is intended as a concurrent reading aid and does not replace the physician's role or other diagnostic tests; it is not for clinical diagnosis of any disease. Performance data for Lung-CAD was established through standalone testing and a clinical reader study. The standalone assessment on 5,000 chest radiograph cases demonstrated high sensitivity (0.898) and specificity (0.894), with an Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve of 0.964. A multiple reader, multiple case (MRMC) retrospective study involving clinical readers evaluating 244 cases showed that reader accuracy, measured by case-level AUC, was significantly improved when aided by Lung-CAD compared to unaided reads (p-value < 0.001), with an AUC improvement of 0.0632. The software level of concern is Moderate, acknowledging that a malfunction could lead to erroneous diagnosis or delay in care, potentially resulting in minor injury.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. Given the standalone Positive Predictive Value of 0.322, what strategies are recommended for clinicians to manage the relatively high number of false positives highlighted by Lung-CAD?; How does the deep learning algorithm differentiate true lung hyperinflation from other conditions that might present similarly on a chest radiograph, such as severe air trapping or bullous disease?; What was the range of experience levels of the clinical readers in the multiple reader, multiple case (MRMC) study, and did the performance improvement with Lung-CAD vary significantly across these different experience levels?; Are there specific patient populations, comorbidities, or image quality variations where Lung-CAD's performance for detecting lung hyperinflation might be less optimal or require additional caution during interpretation?; The Free-Response ROC (FROC) curve terminates at the device’s box-level sensitivity due to the cascaded nature of Lung-CAD predictions; what are the practical implications of this characteristic on its ability to detect all relevant regions of interest?